Islam Khalid insider trades
Islam Khalid has filed 15 Form 4s with the SEC that we hold, for Fennec Pharmaceuticals INC. (FENC) (Director), Gain Therapeutics, Inc. (GANX) (Director) and Processa Pharmaceuticals, Inc. (PCSA) (Director). Across all of them we count 1 purchase worth $50.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 50,000 shares of Gain Therapeutics, Inc. worth $50.0K, dated 2024-08-09. The first filing on our record is dated 2021-07-01 and the latest 2026-07-17.
Fennec Pharmaceuticals INC. (FENC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Gain Therapeutics, Inc. (GANX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-08-09 | P, purchase reported on Form 4 | 50,000 | $50.0K | 2024-08-12 | SEC |
Processa Pharmaceuticals, Inc. (PCSA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1701858) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
